- Home
- RARE vs SAH Comparison
RARE vs SAH Comparison
Compare RARE & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | SAH |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2013 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RARE | SAH |
|---|---|---|
| Price | $21.26 | $61.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 8 |
| Target Price | $66.32 | ★ $78.25 |
| AVG Volume (30 Days) | ★ 2.0M | 292.5K |
| Earning Date | 05-04-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 2.43% |
| EPS Growth | ★ 7.31 | N/A |
| EPS | N/A | ★ 3.42 |
| Revenue | $673,000,000.00 | ★ $9,951,630,000.00 |
| Revenue This Year | $13.40 | $4.63 |
| Revenue Next Year | $42.83 | $4.35 |
| P/E Ratio | ★ N/A | $18.29 |
| Revenue Growth | ★ 20.13 | 0.86 |
| 52 Week Low | $18.41 | $52.00 |
| 52 Week High | $40.54 | $89.38 |
Technical Indicators
Market Signals| Indicator | RARE | SAH |
|---|---|---|
| Relative Strength Index (RSI) | 37.40 | 46.62 |
| Support Level | $19.61 | $60.19 |
| Resistance Level | $25.46 | $65.59 |
| Average True Range (ATR) | 0.98 | 3.37 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 39.06 | 54.90 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About SAH Sonic Automotive Inc.
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 14 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.